229 related articles for article (PubMed ID: 26359460)
1. Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.
Peyvandi S; Buart S; Samah B; Vétizou M; Zhang Y; Durrieu L; Polrot M; Chouaib S; Benihoud K; Louache F; Karray S
Cancer Res; 2015 Oct; 75(20):4292-301. PubMed ID: 26359460
[TBL] [Abstract][Full Text] [Related]
2. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
Zhang Y; Liu Q; Zhang M; Yu Y; Liu X; Cao X
J Immunol; 2009 Mar; 182(6):3801-8. PubMed ID: 19265159
[TBL] [Abstract][Full Text] [Related]
3. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
[TBL] [Abstract][Full Text] [Related]
5. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
6. Differential response of myeloid-derived suppressor cells to the nonsteroidal anti-inflammatory agent indomethacin in tumor-associated and tumor-free microenvironments.
Blidner AG; Salatino M; Mascanfroni ID; Diament MJ; Bal de Kier Joffé E; Jasnis MA; Klein SM; Rabinovich GA
J Immunol; 2015 Apr; 194(7):3452-62. PubMed ID: 25740944
[TBL] [Abstract][Full Text] [Related]
7. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.
Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E
J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227
[TBL] [Abstract][Full Text] [Related]
8. A copper chelate selectively triggers apoptosis in myeloid-derived suppressor cells in a drug-resistant tumor model and enhances antitumor immune response.
Chakraborty P; Das S; Banerjee K; Sinha A; Roy S; Chatterjee M; Choudhuri SK
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):165-75. PubMed ID: 24611750
[TBL] [Abstract][Full Text] [Related]
9. Role of Fas/FasL signaling in regulation of anti-viral response during HSV-2 vaginal infection in mice.
Krzyzowska M; Orłowski P; Bąska P; Bodera P; Zdanowski R; Stankiewicz W
Immunobiology; 2014 Dec; 219(12):932-43. PubMed ID: 25129477
[TBL] [Abstract][Full Text] [Related]
10. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
[TBL] [Abstract][Full Text] [Related]
11. iNOS expression in CD4+ T cells limits Treg induction by repressing TGFβ1: combined iNOS inhibition and Treg depletion unmask endogenous antitumor immunity.
Jayaraman P; Alfarano MG; Svider PF; Parikh F; Lu G; Kidwai S; Xiong H; Sikora AG
Clin Cancer Res; 2014 Dec; 20(24):6439-51. PubMed ID: 25278453
[TBL] [Abstract][Full Text] [Related]
12. Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.
Sanders KL; Fox BA; Bzik DJ
Cancer Immunol Res; 2015 Aug; 3(8):891-901. PubMed ID: 25804437
[TBL] [Abstract][Full Text] [Related]
13. Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage.
Eggert T; Medina-Echeverz J; Kapanadze T; Kruhlak MJ; Korangy F; Greten TF
PLoS One; 2014; 9(11):e112717. PubMed ID: 25401795
[TBL] [Abstract][Full Text] [Related]
14. Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC).
Ostrand-Rosenberg S; Sinha P; Chornoguz O; Ecker C
Cancer Immunol Immunother; 2012 Aug; 61(8):1319-25. PubMed ID: 22546994
[TBL] [Abstract][Full Text] [Related]
15. Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma.
Pham CD; Flores C; Yang C; Pinheiro EM; Yearley JH; Sayour EJ; Pei Y; Moore C; McLendon RE; Huang J; Sampson JH; Wechsler-Reya R; Mitchell DA
Clin Cancer Res; 2016 Feb; 22(3):582-95. PubMed ID: 26405194
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
18. Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer.
Forghani P; Waller EK
Breast Cancer Res Treat; 2015 Aug; 153(1):21-30. PubMed ID: 26208484
[TBL] [Abstract][Full Text] [Related]
19. Mn complex-mediated enhancement of antitumor response through modulating myeloid-derived suppressor cells in drug-resistant tumor.
Das S; Banerjee K; Roy S; Majumder S; Chatterjee M; Majumdar S; Choudhuri SK
In Vivo; 2014; 28(5):909-18. PubMed ID: 25189907
[TBL] [Abstract][Full Text] [Related]
20. Secretory IgM Exacerbates Tumor Progression by Inducing Accumulations of MDSCs in Mice.
Tang CH; Chang S; Hashimoto A; Chen YJ; Kang CW; Mato AR; Del Valle JR; Gabrilovich DI; Hu CC
Cancer Immunol Res; 2018 Jun; 6(6):696-710. PubMed ID: 29650518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
